The neuroprotective action of EPO in experimental PD observed following the direct intra-cerebral injection of the neurotrophin could not be replicated following the systemic administration of daily intra-peritoneal (IP) injections of 5,000 units of EPO/kg (Xue et al., 2007). The gene discussed is EPO; the disease is Parkinson disease.